Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Text messages and videos aim to stop postpartum depression before it starts

NCT ID NCT07587177

Prevention Sponsor: Universidad del Desarrollo Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a digital program called 'What Were We Thinking' (WWWT) to prevent postpartum depression and anxiety in first-time mothers in Chile. The program includes short videos, text message prompts, and a virtual group session. Researchers will compare mothers who receive the program to those who get usual care, measuring symptoms three months later.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
digital psychoeducational program (videos, text messaging, and group session)
What this could lead to
If it works, this could offer a simple, scalable way to prevent postpartum depression and anxiety in new mothers.
What could go wrong
This is a relatively small trial (220 participants) in one country, so results may not apply elsewhere. The program is behavioral, so effects may be modest.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 220 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

May 2026

An estimate. Start dates often move.

Expected to finish

Aug 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * First-time mothers (primiparous women) * Aged 18 years or older * Having a healthy, full-term infant younger than 2 months of age * Receiving prenatal or postnatal care at participating primary health centers in Chile * Having access to a mobile phone capable of receiving calls and text messages * Able to understand and communicate in Spanish Exclusion Criteria: * Severe symptoms of depression or anxiety at baseline requiring immediate specialized mental health treatment * Severe psychosocial problems (e.g., substance abuse, domestic violence, significant cognitive impairment) * Infant born preterm or with severe medical conditions (e.g., genetic disorders or serious neonatal complications) * Inability to provide informed consent or participate in study procedures due to language or cognitive barriers

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Postpartum anxiety are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

postpartum depression prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Postpartum anxiety Postpartum depression (PPD)

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.